Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction.
Takeuchi S, Kohno T, Goda A, Shiraishi Y, Kitamura M, Nagatomo Y, Takei M, Nomoto M, Soejima K, Kohsaka S, Yoshikawa T; West Tokyo Heart Failure Registry Investigators. Takeuchi S, et al. Among authors: nagatomo y. Int J Cardiol. 2024 May 16:132190. doi: 10.1016/j.ijcard.2024.132190. Online ahead of print. Int J Cardiol. 2024. PMID: 38761975
Supra-normal and mildly reduced ejection fraction in women -An overlooked vulnerable subpopulation in heart failure.
Kawai A, Nagatomo Y, Yukino-Iwashita M, Ikegami Y, Takei M, Goda A, Kohno T, Mizuno A, Kitamura M, Nakano S, Sakamoto M, Shiraishi Y, Kohsaka S, Adachi T, Yoshikawa T; as WET-HF investigators. Kawai A, et al. Among authors: nagatomo y. Int J Cardiol. 2024 May 12:132166. doi: 10.1016/j.ijcard.2024.132166. Online ahead of print. Int J Cardiol. 2024. PMID: 38744340
Rationale and protocol of the LAQUA-HF trial: a factorial randomised controlled trial evaluating the effects of neurohormonal and diuretic agents on health-status reported outcomes in heart failure patients.
Shiraishi Y, Ikemura N, Urashima M, Kohno T, Nakano S, Tanaka T, Nagatomo Y, Ikoma T, Ono T, Numasawa Y, Sakamoto M, Nishikawa K, Takei M, Hakuno D, Nakamaru R, Ueda I, Kohsaka S. Shiraishi Y, et al. Among authors: nagatomo y. BMJ Open. 2024 Feb 14;14(2):e076519. doi: 10.1136/bmjopen-2023-076519. BMJ Open. 2024. PMID: 38355194 Free PMC article.
Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers.
Kameda T, Utsunomiya A, Otsuka N, Kubuki Y, Uchida T, Shide K, Kamiunten A, Nakano N, Tokunaga M, Miyazono T, Ito Y, Yonekura K, Kawakita T, Akizuki K, Tahira Y, Karasawa M, Hidaka T, Konagata A, Taniguchi N, Nagatomo Y, Kogo F, Shimizu K, Ueno H, Ishizaki J, Takahashi N, Ikei Y, Hidaka M, Yamaguchi H, Shimoda K. Kameda T, et al. Among authors: nagatomo y. BMC Infect Dis. 2024 Jan 17;24(1):96. doi: 10.1186/s12879-024-09001-z. BMC Infect Dis. 2024. PMID: 38233756 Free PMC article.
254 results